Understanding ANAs, Antinuclear Antibodies — with @AnnKumfer ▶ What does a +ANA mean? ▶ What is the significance of the ANA titer/pattern? ▶ What rheumatic diseases and non-rheumatic diseases are associated with a +ANA? #MedTwitter #Rheumatology #ANA

🆕 Approach to Rheum Labs! 🧪 With the current #rheumatology workforce shortage, better education is needed to increase yield of new patient referrals from referring clinicians: 1️⃣ Joint Pain: when should one refer to #Rheum? 2️⃣ ANA: when should an #ANA be checked? #MedTwitter

🆕 Part II of the 2025 ACR Guideline for Treatment of #SLE 🦋 • Steroid Dosing & Management • HCQ Dosing: exceptions when one can use higher (5-6.5mg/kg) dosage • Comorbidities Guidance #Lupus #Rheumatology #RheumX

Special Announcement 📣! CBN Israel has launched on X to provide you with real time updates, encouragement, and on-the-ground tracking of what's happening each hour in Israel. Follow now!

Annoyed tweets are in random order on your feed again (new X update)? You can change it back to show in chronologic order👇🏽 1️⃣ Click on the “Following” Tab on top right of your feed 2️⃣ Select “Most Recent” instead of Popular

Shining tonight in honor of the Lupus Research Alliance Annual Gala with @LupusResearch Text CONNECT to 274-16 to get alerts on our Lights! Watch tonight's lighting here: https://t.co/hz2FQavwPl

🆕 Visual Abstract with @HealioRheum 🟢 Upadacitinib for Treatment of Giant Cell Arteritis • Upadacitinib (JAKi) 15mg, 7.5mg (vs) PBO • UPA 15mg showed superior efficacy to placebo 📖 by Blockmans et al, NEJM 🔗: https://t.co/Gs1hhbMFs1 #GiantCellArteritis #GCA #RheumX

Have you integrated APOL1 genetic testing into your practice? Discover the No-Cost APOL1 Genotyping Program for eligible patients sponsored by Vertex Pharmaceuticals—helping you deliver precision care without added cost. Learn more today!

🆕 2025 ACR Guideline for Treatment of Systemic #Lupus Erythematosus 🦋 Just Released: Nov 3 #ACR25 🔥 🔸Review organ-specific treatment recommendations 🔸Steroid & HCQ Use Guidance ➠ Read the Full Guideline: https://t.co/jNwvKWbFpE #RheumX #RheumTwitter #Rheum @RheumNow

🆕 Clinical Year in Review at #ACR25 By Dr. Bryant England @UNMC_Rheum 🔶 Review the most impactful studies in #Rheumatology from the past year! ❓ Any studies you would add to the list? #RheumX #RheumTwitter #ACR2025

#ACR25 Had a fantastic time co-moderating this digital #MedEd session with @LauraArneson4 feat amazing talks by Dr. David Leverenz and Dr. Miriah Gillespie-Taylor 🖥️ Catch it on Demand 👉🏼 “Swipe Right on Rheumatology: Engaging Learners & Creating Community in the Digital Age”

🆕 Secrets & Pearls of Rheumatology at #ACR25 | Part 1 by @Janetbirdope 🖐️ Cutaneous Pathology SLE/DM 🧴 Tips for SLE  💪 Cancer Screening in Myositis 🩸 Laboratory Testing 🥶 Raynaud's / Scleroderma 👀 Sjogrens Disease #RheumX  #Lupus #Myositis  #Scleroderma #Sjogrens

🆕 Bench to Bedside: Diagnosis & Treatment of #SLE Nephritis #ACR25 🎤 Talks by Dr. Andrea Fava, Dr. Maria Dall’Ara, & Dr. Anca Askanase 🔹Limitations of Using Proteinuria 🔹Applying 2024 ACR LN Guidelines 🔹How to Treat Refractory Disease #LupusNephritis #Lupus #ACR2025

🆕 ACR 2025 Guidelines for Treatment of Systemic Lupus Erythematosus #ACR25 #Lupus #RheumTwitter

🚨 Hot off the Press / ICYMI 🚨 The FDA has now approved obinutuzumab for use in the treatment of #LupusNephritis 🫘⭐️

🆕 Collaboration with @RheumNow 🔵 3-Part Series on #InterstitialLungDisease Part 3️⃣: Treatment of #ILD 💊 Medication Options for Rx of ILD 💉 🫁 How to Treat Different ILD Subtypes 🚶🏻‍♀️Holistic Approach to Management ❌🚬 #RheumTwitter #PulmTwitter #IPF #PulmX

I wish I discovered this earlier — the sink stays tidy and it attaches to the faucet effortlessly.

🆕 Collaboration with @RheumNow 🔵 3-Part Series on #InterstitialLungDisease Part2️⃣: Diagnosis & Subtypes of #ILD 🫁 👩🏻‍⚕️ What to look for on Physical Exam 🧪 Serologic Testing & Diagnostic Workup 🫁 Differentiating ILD Subtypes on Imaging #RheumX #Pulmonology #MedTwitter #MedX

🆕 Intro to ILD (Part I): the essentials 🫁 Definition & basics 🔬 Key pathology patterns 🧑⚕️ Clinical approach 📋 What rheums need to know ⬇️ Download & learn more: https://t.co/Fn76PiGsPl Created by @MithuRheum | via @RheumNow for our Rheum to Breathe: ILD Campaign

🆕 Collaboration with @RheumNow 🔵 3-Part Series on #InterstitialLungDisease Part I: Introduction to #ILD 🫁 🔹Learn about different subtypes of ILD 🔹Signs/Symptoms of Initial Presentation 🔹What is the prevalence of ILD in various SARDs? #RheumTwitter #PulmTwitter #RheumX

And for a deep dive, check out this recent ACR on Air podcast episode on #Behcets ft. Dr. Johannes Nowatzky 🎧 https://t.co/sDruFjl12v

🆕 Behçet's Disease: Let’s explore this multi-system #vasculitis 💫 👄 Oral/Genital Ulcers 🩸 DVT, Arterial Aneurysm 👁️ Uveitis 🧠 Neurologic Involvement 🖐️ Cutaneous / Pathergy #RheumTwitter #Behcets #RheumX

Trade screen time for creativity. The LED Note Board lets kids draw and write in neon colors, making playtime fun, interactive, and completely device-free.

One thing I hear a lot from fellows (whether going into academics or PP) nationally is they wish fellowship included more training on the business of medicine… Such as billing/coding, RVUs, EHR management & documentation, insurance navigation / prior auths.

And check out this great tweetorial by @AliDuarteMD for a deep dive into the new ACR Guidelines for #LupusNephritis!